T. T. Van-sloten, R. M. Henry, J. M. Dekker, G. Nijpels, T. Unger et al., Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study, Hypertension, vol.64, pp.1299-305, 2014.

C. M. Sena, A. M. Pereira, and R. Seiça, Endothelial dysfunction-a major mediator of diabetic vascular disease, Biochim Biophys Acta, vol.1832, pp.2216-2247, 2013.

C. Roche, M. Besnier, R. Cassel, N. Harouki, D. Coquerel et al., Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice, Am J Physiol Heart Circ Physiol, vol.308, pp.1020-1029, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01850659

X. Zhao, A. Dey, O. P. Romanko, D. W. Stepp, M. H. Wang et al., Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats, Am J Physiol Regul Integr Comp Physiol, vol.288, pp.188-96, 2005.

J. Bellien, R. Joannides, and V. Richard, Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: a promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?, Pharmacol Ther, vol.131, pp.1-17, 2011.

C. Morisseau and B. D. Hammock, Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health, Annu Rev Pharmacol Toxicol, vol.53, pp.37-58, 2013.

J. Bellien, M. Iacob, R. , I. Lucas, D. Monteil et al., Epoxyeicosatrienoic acids contribute with altered NO and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension, Circulation, vol.125, pp.1266-75, 2012.

L. N. Zhang, J. Vincelette, D. Chen, R. D. Gless, S. K. Anandan et al., Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension, Eur J Pharmacol, vol.654, pp.68-74, 2011.

M. H. Gangadhariah, B. W. Dieckmann, L. Lantier, L. Kang, D. H. Wasserman et al., Cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids contribute to insulin sensitivity in mice and in humans, Diabetologia, vol.60, pp.1066-75, 2017.

T. Duflot, T. Pereira, C. Roche, M. Iacob, P. Cardinael et al., A sensitive LC-MS/ MS method for the quantification of regioisomers of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in human plasma during endothelial stimulation, Anal Bioanal Chem, vol.409, pp.1845-55, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01928046

J. Bellien, M. Iacob, C. Monteil, R. Duflot, T. Thuillez et al., Physiological role of endothelin-1 in flow-mediated vasodilatation in humans and impact of cardiovascular risk factors, J Hypertens, vol.35, pp.1204-1216, 2017.

D. Li, Y. Cui, C. Morisseau, S. J. Gee, C. S. Bever et al., Nanobody based immunoassay for human soluble epoxide hydrolase detection using polymeric horseradish peroxidase (PolyHRP) for signal enhancement: the rediscovery of PolyHRP?, Anal Chem, vol.89, pp.6248-56, 2017.

B. Borhan, T. Mebrahtu, S. Nazarian, M. J. Kurth, and B. D. Hammock, Improved radiolabeled substrates for soluble epoxide hydrolase, Anal Biochem, vol.231, pp.188-200, 1995.

M. D. Enderle, N. Benda, R. M. Schmuelling, H. U. Haering, and M. Pfohl, Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects, Diabetes Care, vol.21, pp.271-278, 1998.

M. F. Meyer, D. Lieps, H. Schatz, and M. Pfohl, Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction, Microvasc Res, vol.76, pp.61-66, 2008.

K. K. Naka, K. Papathanassiou, A. Bechlioulis, N. Kazakos, K. Pappas et al., Determinants of vascular function in patients with type 2 diabetes, Cardiovasc Diabetol, vol.11, p.127, 2012.

M. G. Modena, L. Bonetti, F. Coppi, F. Bursi, and R. Rossi, Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women, J Am Coll Cardiol, vol.40, pp.505-515, 2002.

L. Ghiadoni, D. Versari, A. Magagna, I. Kardasz, Y. Plantinga et al., Ramipril dose-dependently increases nitric oxide availability in the radial artery of essential hypertension patients, J Hypertens, vol.25, pp.361-367, 2007.

F. Cosentino, K. Hishikawa, Z. S. Katusic, and T. F. Lüscher, High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells, Circulation, vol.96, issue.1, pp.25-33, 1997.

R. Adela, S. K. Nethi, P. K. Bagul, A. K. Barui, S. Mattapally et al., Hyperglycaemia enhances nitric oxide production in diabetes: a study from South Indian patients, PLoS ONE, vol.10, p.125270, 2015.

?. Fast, convenient online submission ? thorough peer review by experienced researchers in your field ? rapid publication on acceptance ? support for research data, including large and complex data types ? gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research

, Choose BMC and benefit from

G. E. Mcveigh, G. M. Brennan, G. D. Johnston, B. J. Mcdermott, L. T. Mcgrath et al., Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus, Diabetologia, vol.35, pp.771-777, 1992.

T. Heitzer, K. Krohn, S. Albers, and T. Meinertz, Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus, Diabetologia, vol.43, pp.1435-58, 2000.

P. Minuz, H. Jiang, C. Fava, L. Turolo, S. Tacconelli et al., Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease, Hypertension, vol.51, pp.1379-85, 2008.

Y. Issan, E. Hochhauser, A. Guo, K. H. Gotlinger, R. Kornowski et al., Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia, Prostaglandins Other Lipid Mediat, pp.15-21, 2013.

K. Makita, K. Takahashi, A. Karara, H. R. Jacobson, J. R. Falck et al., Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet, J Clin Invest, vol.94, pp.2414-2434, 1994.

M. H. Wang, A. Smith, Y. Zhou, H. H. Chang, S. Lin et al., Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension, Hypertension, vol.42, pp.594-603, 2003.

M. Furukawa, M. Nishimura, D. Ogino, R. Chiba, I. Ikai et al., Cytochrome p450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver, Cancer Sci, vol.95, pp.520-529, 2004.

H. Huang, C. Morisseau, J. Wang, T. Yang, J. R. Falck et al., Increasing or stabilizing renal epoxyeicosatrienoic acid production attenuates abnormal renal function and hypertension in obese rats, Am J Physiol Renal Physiol, vol.293, pp.342-351, 2007.

B. M. De-taeye, C. Morisseau, J. Coyle, J. W. Covington, A. Luria et al., Expression and regulation of soluble epoxide hydrolase in adipose tissue, Obesity (Silver Spring), vol.18, pp.489-98, 2010.

Y. Liu, H. Dang, D. Li, W. Pang, B. D. Hammock et al., Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice, PLoS ONE, vol.7, p.39165, 2012.

D. Ai, Y. Fu, D. Guo, H. Tanaka, N. Wang et al., Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo, Proc Natl Acad Sci USA, vol.104, pp.9018-9041, 2007.

M. Poreba, P. Rostoff, A. Siniarski, M. Mostowik, R. Golebiowska-wiatrak et al., Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease, Cardiovasc Diabetol, vol.17, p.29, 2018.

M. Poreba, M. Mostowik, A. Siniarski, R. Golebiowska-wiatrak, K. P. Malinowski et al., Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes, Cardiovasc Diabetol, vol.16, p.50, 2017.

N. C. Ward, J. Rivera, J. Hodgson, I. B. Puddey, L. J. Beilin et al., Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans, Circulation, vol.110, pp.438-481, 2004.

H. O. Steinberg, G. Brechtel, A. Johnson, N. Fineberg, and A. D. Baron, Insulinmediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release, J Clin Invest, vol.94, pp.1172-1181, 1994.

A. D. Baron, H. O. Steinberg, H. Chaker, R. Leaming, A. Johnson et al., Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans, J Clin Invest, vol.96, pp.786-92, 1995.

H. H. Hou, B. D. Hammock, K. H. Su, C. Morisseau, Y. R. Kou et al., N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase, Cardiovasc Res, vol.93, pp.120-129, 2012.

H. H. Hou, Y. J. Liao, S. H. Hsiao, S. K. Shyue, and T. S. Lee, Role of phosphatase activity of soluble epoxide hydrolase in regulating simvastatin-activated endothelial nitric oxide synthase, Sci Rep, vol.5, p.13524, 2015.

S. B. Williams, A. B. Goldfine, F. K. Timimi, H. H. Ting, M. A. Roddy et al., Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo, Circulation, vol.97, pp.1695-701, 1998.

H. Kawano, T. Motoyama, O. Hirashima, N. Hirai, Y. Miyao et al., Hyperglycemia rapidly suppresses flowmediated endothelium-dependent vasodilation of brachial artery, J Am Coll Cardiol, vol.34, pp.146-54, 1999.

L. M. Title, P. M. Cummings, K. Giddens, and B. A. Nassar, Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E, J Am Coll Cardiol, vol.36, pp.2185-91, 2000.

J. A. Beckman, A. B. Goldfine, M. B. Gordon, and M. A. Creager, Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans, Circulation, vol.103, pp.1618-1641, 2001.

G. Arcaro, A. Cretti, S. Balzano, A. Lechi, M. Muggeo et al., Insulin causes endothelial dysfunction in humans: sites and mechanisms, Circulation, vol.105, pp.576-82, 2002.

U. Campia, G. Sullivan, M. B. Bryant, M. A. Waclawiw, M. J. Quon et al., Insulin impairs endothelium-dependent vasodilation independent of insulin sensitivity or lipid profile, Am J Physiol Heart Circ Physiol, vol.286, pp.76-82, 2004.

N. L. Weintraub, X. Fang, T. L. Kaduce, M. Vanrollins, P. Chatterjee et al., Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids, Circ Res, vol.81, pp.258-67, 1997.

J. Hu, S. Dziumbla, J. Lin, S. I. Bibli, S. Zukunft et al., Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy, Nature, vol.552, pp.248-52, 2017.

A. Luria, A. Bettaieb, Y. Xi, G. J. Shieh, H. C. Liu et al., Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance, Proc Natl Acad Sci USA, vol.108, pp.9038-9081, 2011.